ID: ALA3319287

Max Phase: Preclinical

Molecular Formula: C12H12F3NO5

Molecular Weight: 307.22

Molecule Type: Small molecule

Representations

Canonical SMILES:  CCOC(=O)C(C[N+](=O)[O-])c1cccc(OC(F)(F)F)c1

Standard InChI:  InChI=1S/C12H12F3NO5/c1-2-20-11(17)10(7-16(18)19)8-4-3-5-9(6-8)21-12(13,14)15/h3-6,10H,2,7H2,1H3

Standard InChI Key:  BEOUNFQWFPIINM-UHFFFAOYSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 307.22

Molecular Weight (Monoisotopic): 307.0668

AlogP: 2.51

#Rotatable Bonds: 6

Polar Surface Area: 78.67

Molecular Species: NEUTRAL

HBA: 5

HBD: 0

#RO5 Violations: 0

HBA (Lipinski): 6

HBD (Lipinski): 0

#RO5 Violations (Lipinski): 0

CX Acidic pKa: 8.62

CX Basic pKa:

CX LogP: 3.35

CX LogD: 3.33

Aromatic Rings: 1

Heavy Atoms: 21

QED Weighted: 0.46

Np Likeness Score: -0.99

References

1. Csuk R, Heller L, Siewert B, Gutnov A, Seidelmann O, Wendisch V..  (2014)  β-Nitro substituted carboxylic acids and their cytotoxicity.,  24  (16): [PMID:25001484] [10.1016/j.bmcl.2014.06.021]

Source

Source(1):

• Scientific Literature